Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Japan panel says people 65 or older should get COVID vaccine priority

Published 12/24/2020, 10:22 PM
Updated 12/25/2020, 04:11 AM
© Reuters. FILE PHOTO:  Coronavirus disease (COVID-19) outbreak, in Tokyo

By Kiyoshi Takenaka

TOKYO (Reuters) - A Japanese health ministry panel said on Friday that people aged 65 or older should get priority for vaccination against COVID-19 as the government sets guidelines that will also prioritise frontline healthcare workers and those with medical conditions.

The panel also specified chronic heart disease, chronic respiratory disease and chronic kidney disease, among others, as underlying conditions that should determine priority for the vaccine.

The recommendations would include 36 million elderly people and 8.2 million people with medical conditions in the first group to receive vaccine shots.

Another government panel this week recommended that priority be given to frontline medical professionals and workers at elderly care facilities, while the elderly and those with underlying health conditions should also receive priority.

Japan, with a population of 126 million, has agreements to buy 290 million vaccine doses from Pfizer Inc (NYSE:PFE), AstraZeneca (NASDAQ:AZN) Plc and Moderna (NASDAQ:MRNA) Inc, or enough for 145 million people.

Japan is currently facing a third wave of coronavirus infections, putting the nation's medical system under heavy strain.

Prime Minister Yoshihide Suga will hold a news conference from 6 p.m. (0900 GMT) on Friday about the government response to the pandemic.

Five national groups of doctors and other medical workers made an emergency request on Friday to Suga and Health Minister Norihisa Tamura, asking for strong anti-infection measures and support for the medical sector.

With hospitals equipped for COVID-19 patients filling up, other hospitals are being forced to accept them, said Tsuyoshi Masuda, president of the Japan Federation of Democratic Medical Institutions, one of the groups.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

"Naturally, they run much higher risk of in-house infection than those equipped to treat COVID-19 patients," Masuda told a news conference.

"These small and medium-sized hospitals, which have been supporting medical services in their respective regions, are facing a crisis that is threatening their survival."

Tokyo reported 884 coronavirus infections on Friday, near Thursday's record 888.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.